USPTO serial 77852766
CHONDROTISSUE BY BIOTISSUE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- LE, KHANH M
- Law office
- TMO LAW OFFICE 113 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with CHONDROTISSUE BY BIOTISSUE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Patrick J. Jennings
Patrick J. Jennings Pillsbury Winthrop Shaw Pittman LLP2300 N St., N.W.Washington, DC 20037UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Polymer-based pharmaceutical preparations for use in tissue and organ transplantation, namely, regenerative, reparative and hemostatic preparations, consisting of hyaluronic acid and bioresorbable polyglycolic acid polymers; biomedical polymer-based pharmaceutical preparations, namely, preparations for use in tissue and organ transplantation, namely regenerative, reparative and hemostatic preparations, consisting of hyaluronic acid and bioresorbable polyglycolic acid polymers | ACTIVE | — |
| 010 | Medical devices in the nature of surgical implants primarily comprising artificial tissue, also consisting of biological cartilage, intervertebral disc, meniscus, tendon, ligament, bone and connective tissue substitutes intended for subsequent implantation, all sold as a unit; surgical implants primarily comprising artificial tissue, also consisting of hyaluronic acid, biological polymers, bioresorbable polymers and combinations thereof, all sold as a unit; biological surgical implants primarily comprising artificial tissue also consisting of hyaluronic acid, biological polymers, bioresorbable polymers and combinations thereof, all sold as a unit; health care products in the nature of surgical implants primarily comprising artificial tissue, also consisting of biological cartilage, intervertebral disc, meniscus, tendon, ligament, bone and connective tissue substitutes intended for subsequent implantation, all sold as a unit; products of tissue engineering, namely, surgical implants and modified surgical implants primarily comprising artificial material, also consisting of biological materials, all sold as a unit; tissue precursors, namely, surgical implants primarily comprising artificial material also consisting of molecules, namely, hyaluronic acid, biological polymers, bioresorbable polymers and combinations thereof produced in vitro for replacing and supporting the function of absent or injured body parts, all sold as a unit; artificial cartilage replacements and tissue replacements, namely, primarily artificial substitutes for bones, cartilage, ligaments, and tendons, also consisting of implants of hyaluronic acid, biological polymers, bioresorbable polymers and combinations thereof, all sold as a unit; biological replacement and biological protection of mesenchymal tissue, namely, primarily artificial substitutes for bones, cartilage, ligaments and tendons also consisting of implants of hyaluronic acid, biological polymers, bioresorbable polymers and combinations thereof, all sold as a unit | ACTIVE | — |
| 042 | Research and development of pharmaceutical preparations and medicines; consultancy in the field of biomedicine | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 30, 2010 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Aug 30, 2010 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Aug 18, 2010 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 1, 2010 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 1, 2010 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 1, 2010 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 25, 2010 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 26, 2009 | TAEA | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED | — |
| Oct 26, 2009 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Oct 24, 2009 | MPMK | NOTICE OF PSEUDO MARK MAILED | — |
| Oct 23, 2009 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 23, 2009 | NWAP | NEW APPLICATION ENTERED | — |